Login to Your Account



Biota Settles with GSK

Tough Biotech Lesson Learned: Fighting Big Pharma is Costly

By Nuala Moran


Wednesday, August 13, 2008
LONDON - Biota Holdings Ltd. has written to shareholders to explain why it dropped a four year-long legal action against GlaxoSmithKline plc over a claim that the London-based pharma company failed to promote Biota's flu treatment Relenza properly. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription